Skip to main content

Advertisement

Table 7 ATP/NADH/NADPH/Co-Q10.

From: Effect of a vitamin/mineral supplement on children and adults with autism

  Units Neuro-typicals
(n = 44)
Arizona Treatment Group
(n = 18)
Arizona Placebo Group
(n = 22)
    Pre Post % change p-value Pre Post % change p-value
ATP
(plasma)
nmol/l 18.5
+/- 4.7
15.5
+/- 3.7
19.3
+/- 2.3
+25% 0.00001 14.0
+/- 4.9
15.6
+/- 3.7
+11% 0.08
NADH
(RBC)
nmol/ml 20.7
+/- 4.3
15.7
+/- 4.5
20.1
+/- 5.1
+28% .00002 15.3
+/- 3.9
16.4
+/- 4.1
+8% 0.06
NADPH
(RBC)
nmol/ml 30.9
+/- 8.5
23.0
+/- 7.7
29.9
+/- 7.1
+30% 0.001 21.9
+/- 5.3
23.9
+/- 7.2
+9% n.s.
CoQ10
(plasma)
ug/ml 0.60
+/- 0.16
0.56
+/- 0.14
1.41
+/- 0.58
+153% 0.00001 0.57
+/- 0.18
0.71
+/- 0.26
+26% 0.01
  1. The average levels of biomarkers measured in the Neurotypical group and the Autism Treatment and Autism Placebo groups (pre and post) who completed the study are reported below, along with their standard deviations. The p-value for a t-test comparison of the change in the level is reported. If the p-value is below 0.05, then the result is highlighted.